DE60126802D1 - Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese - Google Patents

Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese

Info

Publication number
DE60126802D1
DE60126802D1 DE60126802T DE60126802T DE60126802D1 DE 60126802 D1 DE60126802 D1 DE 60126802D1 DE 60126802 T DE60126802 T DE 60126802T DE 60126802 T DE60126802 T DE 60126802T DE 60126802 D1 DE60126802 D1 DE 60126802D1
Authority
DE
Germany
Prior art keywords
cyclopeptides
preparation
inhibiting
angiogenesis
stimulating angiogenesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60126802T
Other languages
English (en)
Other versions
DE60126802T2 (de
Inventor
Natacha Betz
Andreas Bikfalvi
Gerard Deleris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universite Victor Segalen Bordeaux 2
Universite des Sciences et Tech (Bordeaux 1)
Commissariat a lEnergie Atomique et aux Energies Alternatives CEA
Original Assignee
Universite Victor Segalen Bordeaux 2
Commissariat a lEnergie Atomique CEA
Universite des Sciences et Tech (Bordeaux 1)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universite Victor Segalen Bordeaux 2, Commissariat a lEnergie Atomique CEA, Universite des Sciences et Tech (Bordeaux 1) filed Critical Universite Victor Segalen Bordeaux 2
Publication of DE60126802D1 publication Critical patent/DE60126802D1/de
Application granted granted Critical
Publication of DE60126802T2 publication Critical patent/DE60126802T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE60126802T 2000-10-04 2001-10-02 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese Expired - Lifetime DE60126802T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0012654A FR2814744B1 (fr) 2000-10-04 2000-10-04 Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese
FR0012654 2000-10-04
PCT/FR2001/003049 WO2002028895A2 (fr) 2000-10-04 2001-10-02 Cyclopeptides, leur procede de preparation et leur utilisation comme inhibiteur ou activateur de l'angiogenese

Publications (2)

Publication Number Publication Date
DE60126802D1 true DE60126802D1 (de) 2007-04-05
DE60126802T2 DE60126802T2 (de) 2007-11-08

Family

ID=8854977

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60126802T Expired - Lifetime DE60126802T2 (de) 2000-10-04 2001-10-02 Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese

Country Status (15)

Country Link
US (2) USRE44022E1 (de)
EP (1) EP1328546B1 (de)
JP (1) JP4303958B2 (de)
AT (1) ATE354589T1 (de)
AU (2) AU9394801A (de)
CA (1) CA2424506A1 (de)
DE (1) DE60126802T2 (de)
DK (1) DK1328546T3 (de)
ES (1) ES2282293T3 (de)
FR (1) FR2814744B1 (de)
IL (1) IL155117A0 (de)
NO (1) NO20031377L (de)
NZ (1) NZ525069A (de)
RU (1) RU2249599C2 (de)
WO (1) WO2002028895A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2513044A1 (en) 2002-03-01 2004-08-05 Dyax Corp. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7211240B2 (en) * 2002-03-01 2007-05-01 Bracco International B.V. Multivalent constructs for therapeutic and diagnostic applications
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
US7794693B2 (en) * 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
CA2517939C (en) * 2003-03-03 2015-11-24 Dyax Corp. Peptides that specifically bind hgf receptor (cmet) and uses thereof
US20090093016A1 (en) * 2006-01-17 2009-04-09 N.V. Organon Selective Enzymatic Hydrolysis of C-Terminal Tert-Butyl Esters of Peptides
US8227413B2 (en) 2006-10-19 2012-07-24 Ramot At Tel-Aviv University Ltd. Compositions and methods for inducing angiogenesis
ES2622155T3 (es) 2009-07-24 2017-07-05 Advanced Accelerator Applications S.A. Compuestos moduladores de la actividad VEGF y usos de los mismos
FR2969999B1 (fr) 2011-01-03 2013-02-08 Commissariat Energie Atomique Conjugue, son procede de preparation et ses utilisations
US9815867B2 (en) 2012-09-03 2017-11-14 The University Of Tokyo Peptide for inhibiting vascular endothelial growth factor receptor
CN103724290B (zh) * 2013-11-15 2015-04-29 浙江大学 一种环肽化合物clavatustide A及其产生菌、制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4310643A1 (de) * 1993-04-01 1994-10-06 Merck Patent Gmbh Cyclische Adhäsionsinhibitoren
US5939383A (en) * 1996-11-15 1999-08-17 Remacle; Jose Cyclic peptides bearing a tail designed for subsequent chemical coupling and process for preparing same
EP1056773A2 (de) * 1998-02-11 2000-12-06 Resolution Pharmaceuticals Inc. Für angiogenese spezifische moleküle
EP1156824A2 (de) * 1999-03-11 2001-11-28 EntreMed, Inc. Zubereitungen und verfahren für die behandlung von krebs und hyperproliferierenden krankheiten

Also Published As

Publication number Publication date
RU2249599C2 (ru) 2005-04-10
US20040092434A1 (en) 2004-05-13
FR2814744A1 (fr) 2002-04-05
US7199100B2 (en) 2007-04-03
NZ525069A (en) 2004-09-24
JP2004510784A (ja) 2004-04-08
NO20031377D0 (no) 2003-03-26
NO20031377L (no) 2003-05-02
ATE354589T1 (de) 2007-03-15
DK1328546T3 (da) 2007-06-04
ES2282293T3 (es) 2007-10-16
IL155117A0 (en) 2003-10-31
USRE44022E1 (en) 2013-02-19
EP1328546A2 (de) 2003-07-23
AU2001293948B2 (en) 2005-11-03
JP4303958B2 (ja) 2009-07-29
CA2424506A1 (en) 2002-04-11
FR2814744B1 (fr) 2002-11-29
DE60126802T2 (de) 2007-11-08
WO2002028895A2 (fr) 2002-04-11
WO2002028895A3 (fr) 2002-06-06
EP1328546B1 (de) 2007-02-21
AU9394801A (en) 2002-04-15

Similar Documents

Publication Publication Date Title
DE60126802D1 (de) Cyclopeptide, verfahren zu ihrer herstellung und ihre verwendung zur hemmung oder stimulierung von angiogenese
ATE345682T1 (de) In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
AU2003264419A1 (en) Kdr peptides and vaccines containing the same
DE69925156D1 (de) Verfahren und zusammensetzungen zur behandlung von zellproliferationsstörungen
SE9300140D0 (sv) Solid substrate
GB9927292D0 (en) Security system
AU5155996A (en) Control of pod dehiscence
PT989858E (pt) Compostos que imitam os peptideos inibidores de cd28/ctla-composicoes farmaceuticas feitas a partir dos referidos e um metodo de usar os referidos
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
ATE233784T1 (de) Verfahren zur proteinaufreinigung aus einer proteinhaltigen lösung
NO981748L (no) Nytt DNA, samt en fremgangsmÕte for fremstilling av protein ved anvendelse av dette
ATE332379T1 (de) Menschliche dnase resistent gegen actininhibitoren
FI952094A0 (fi) Ihmisen serotoniinireseptoria (5-HT4B)koodaava DNA ja sen käyttö
DE69923460D1 (de) Verfahren zur herstellung von ring-modifizierten zyklischen peptidanalogen
BR0317537A (pt) Processo para preparar aminoácidos em organismos transgênicos, construção de ácido nucleico, vetor, organismo procariótico ou eucariótico transgênico, uso dos organismos transgênicos, e, sequencia de aminoácidos
AU6378994A (en) Plant promoter, microorganisms and plant cells containing a unit for the expression of a protein of interest comprising said promoter
ATE291088T1 (de) Immunologisch aktive proteine von borrelia burgdorferi, dafür kodierende nukleinsäuren sowie deren verwendung in testkits und als impfstoffe
DE59608651D1 (de) Verfahren zur sequenzierung durch oligomerhybridisierung
DE60219361D1 (de) Verfahren zur rekombinanten herstellung von plazenta wachstumsfaktor
DE69837265D1 (de) Polypeptide zur regenerierung des nervensystems
DK0773999T3 (da) OR-1, en orphan-receptor tilhørende kernereceptorfamilien
SE9401380D0 (sv) Ny celltillväxt-relaterad peptid och användning därav
ATE325812T1 (de) Menschliches, gebärmutterkrebs-spezifisches suppressorprotein, für das protein kodieres polynukleotid, mit dem polynukleotid transformierte zelle und verfahren zur unterdrückung der proliferation von krebszellen unter verwendung des expressionsvektors
ATE401408T1 (de) Tapetum-spezifische promotoren
DE69827880D1 (de) Iga1-protease fragment als trägerpeptid

Legal Events

Date Code Title Description
8364 No opposition during term of opposition